Consideration of Joint Commercialization of GCP-006 with 五稜化薬
A partnership initiative to explore the potential for joint development and commercialization with 五稜化薬 of GCP-006, a navigation drug for breast cancer that uses a functional fluorescent probe.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.